Back to top

CytomX Therapeutics Adds Dr. Fuchs to Board

An announcement from CytomX Therapeutics ( ($CTMX) ) is now available. On July 24, 2026, CytomX Therapeutics appointed Charles Fuchs, M.D., M.P.H.,...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

CytomX Therapeutics, Inc. (CTMX)